<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: TAPIMMUNE INC.xfr; Date: 2015%2D05%2D15T20:31:27 -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://tapimmune.com/role/DocumentAndEntityInformation" xlink:href="tpiv-20150331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/BalanceSheets" xlink:href="tpiv-20150331.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/BalanceSheetsParenthetical" xlink:href="tpiv-20150331.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/StatementsOfOperations" xlink:href="tpiv-20150331.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/CondensedConsolidatedStatementOfStockholdersEquityDeficit" xlink:href="tpiv-20150331.xsd#CondensedConsolidatedStatementOfStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/CondensedConsolidatedStatementOfStockholdersEquityDeficitParenthetical" xlink:href="tpiv-20150331.xsd#CondensedConsolidatedStatementOfStockholdersEquityDeficitParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/StatementsOfCashFlows" xlink:href="tpiv-20150331.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/StatementsOfCashFlowsParenthetical" xlink:href="tpiv-20150331.xsd#StatementsOfCashFlowsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/NatureOfOperations" xlink:href="tpiv-20150331.xsd#NatureOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/BasisOfPresentation" xlink:href="tpiv-20150331.xsd#BasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/LiquidityAndFinancialCondition" xlink:href="tpiv-20150331.xsd#LiquidityAndFinancialCondition" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/SignificantAccountingPolicies" xlink:href="tpiv-20150331.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/PotentiallyDilutiveSecurities" xlink:href="tpiv-20150331.xsd#PotentiallyDilutiveSecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/DerivativeLiability-WarrantsAndDerivativeLiabilityConversionOption" xlink:href="tpiv-20150331.xsd#DerivativeLiability-WarrantsAndDerivativeLiabilityConversionOption" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/PromissoryNote" xlink:href="tpiv-20150331.xsd#PromissoryNote" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/CapitalStock" xlink:href="tpiv-20150331.xsd#CapitalStock" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/ContingenciesAndCommitments" xlink:href="tpiv-20150331.xsd#ContingenciesAndCommitments" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/SignificantAccountingPoliciesPolicies" xlink:href="tpiv-20150331.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/PotentiallyDilutiveSecuritiesTable" xlink:href="tpiv-20150331.xsd#PotentiallyDilutiveSecuritiesTable" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/DerivativeWarrantLiabilityAndFairValueTables" xlink:href="tpiv-20150331.xsd#DerivativeWarrantLiabilityAndFairValueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/CapitalStockTables" xlink:href="tpiv-20150331.xsd#CapitalStockTables" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/LiquidityAndFinancialConditionDetailsNarrtive" xlink:href="tpiv-20150331.xsd#LiquidityAndFinancialConditionDetailsNarrtive" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/PotentiallyDilutiveSecuritiesDetails" xlink:href="tpiv-20150331.xsd#PotentiallyDilutiveSecuritiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/PromissoryNotesRelatedPartyDetailsNarrative" xlink:href="tpiv-20150331.xsd#PromissoryNotesRelatedPartyDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/DerivativeLiability-WarrantsAndDerivativeLiability-ConversionOptionDetails" xlink:href="tpiv-20150331.xsd#DerivativeLiability-WarrantsAndDerivativeLiability-ConversionOptionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/DerivativeLiability-WarrantsAndDerivativeLiability-ConversionOptionDetails1" xlink:href="tpiv-20150331.xsd#DerivativeLiability-WarrantsAndDerivativeLiability-ConversionOptionDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/DerivativeLiability-WarrantsAndDerivativeLiabilityConversionOptionDetails2" xlink:href="tpiv-20150331.xsd#DerivativeLiability-WarrantsAndDerivativeLiabilityConversionOptionDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/DerivativeLiability-WarrantsAndDerivativeLiabilityConversionOptionDetails3" xlink:href="tpiv-20150331.xsd#DerivativeLiability-WarrantsAndDerivativeLiabilityConversionOptionDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/CapitalStockDetails" xlink:href="tpiv-20150331.xsd#CapitalStockDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://tapimmune.com/role/ContingenciesAndCommitmentsDetailsNarrative" xlink:href="tpiv-20150331.xsd#ContingenciesAndCommitmentsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/BalanceSheets" xlink:title="00000002 - Statement - Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidExpenseNoncurrent" xlink:label="loc_us-gaapPrepaidExpenseNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPrepaidExpenseNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesFairValueDisclosure" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesFairValueDisclosure" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDerivativeLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:label="loc_us-gaapDevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapDevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherExtraordinaryGainLoss" xlink:label="loc_us-gaapOtherExtraordinaryGainLoss" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherExtraordinaryGainLoss" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherExtraordinaryGainLoss" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeLossBeforeTax" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossBeforeTax" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherComprehensiveIncomeLossBeforeTax" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/CondensedConsolidatedStatementOfStockholdersEquityDeficit" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY (DEFICIT) (Unaudited)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/CondensedConsolidatedStatementOfStockholdersEquityDeficitParenthetical" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY (DEFICIT) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ExtinguishmentOfDebtGainLossIncomeTax" xlink:label="loc_us-gaapExtinguishmentOfDebtGainLossIncomeTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapExtinguishmentOfDebtGainLossIncomeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestAndDebtExpense" xlink:label="loc_us-gaapInterestAndDebtExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapInterestAndDebtExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInDerivativeLiabilities" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDerivativeLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashPeriodIncreaseDecrease" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/StatementsOfCashFlowsParenthetical" xlink:title="00000008 - Statement - Statements of Cash Flows (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/NatureOfOperations" xlink:title="00000009 - Disclosure - NATURE OF OPERATIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/BasisOfPresentation" xlink:title="00000010 - Disclosure - BASIS OF PRESENTATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/LiquidityAndFinancialCondition" xlink:title="00000011 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/SignificantAccountingPolicies" xlink:title="00000012 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/PotentiallyDilutiveSecurities" xlink:title="00000013 - Disclosure - POTENTIALLY DILUTIVE SECURITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/DerivativeLiability-WarrantsAndDerivativeLiabilityConversionOption" xlink:title="00000014 - Disclosure - DERIVATIVE LIABILITY - WARRANTS AND DERIVATIVE LIABILITY &#8211; CONVERSION OPTION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/PromissoryNote" xlink:title="00000015 - Disclosure - PROMISSORY NOTE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/CapitalStock" xlink:title="00000016 - Disclosure - CAPITAL STOCK" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/ContingenciesAndCommitments" xlink:title="00000017 - Disclosure - CONTINGENCIES AND COMMITMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/SignificantAccountingPoliciesPolicies" xlink:title="00000018 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/PotentiallyDilutiveSecuritiesTable" xlink:title="00000019 - Disclosure - POTENTIALLY DILUTIVE SECURITIES (Table)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/DerivativeWarrantLiabilityAndFairValueTables" xlink:title="00000020 - Disclosure - DERIVATIVE WARRANT LIABILITY AND FAIR VALUE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/CapitalStockTables" xlink:title="00000021 - Disclosure - CAPITAL STOCK (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/LiquidityAndFinancialConditionDetailsNarrtive" xlink:title="00000022 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION (Details Narrtive)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/PotentiallyDilutiveSecuritiesDetails" xlink:title="00000023 - Disclosure - POTENTIALLY DILUTIVE SECURITIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/PromissoryNotesRelatedPartyDetailsNarrative" xlink:title="00000024 - Disclosure - PROMISSORY NOTES, RELATED PARTY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/DerivativeLiability-WarrantsAndDerivativeLiability-ConversionOptionDetails" xlink:title="00000025 - Disclosure - DERIVATIVE LIABILITY - WARRANTS AND DERIVATIVE LIABILITY -  CONVERSION OPTION (Details )" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/DerivativeLiability-WarrantsAndDerivativeLiability-ConversionOptionDetails1" xlink:title="00000026 - Disclosure - DERIVATIVE LIABILITY - WARRANTS AND DERIVATIVE LIABILITY -  CONVERSION OPTION (Details 1)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet" xlink:label="loc_us-gaapDerivativeFairValueOfDerivativeNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:label="loc_us-gaapDerivativeFairValueOfDerivativeLiability" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDerivativeFairValueOfDerivativeNet" xlink:to="loc_us-gaapDerivativeFairValueOfDerivativeLiability" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/DerivativeLiability-WarrantsAndDerivativeLiabilityConversionOptionDetails2" xlink:title="00000027 - Disclosure - DERIVATIVE LIABILITY - WARRANTS AND DERIVATIVE LIABILITY &#8211; CONVERSION OPTION (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/DerivativeLiability-WarrantsAndDerivativeLiabilityConversionOptionDetails3" xlink:title="00000028 - Disclosure - DERIVATIVE LIABILITY - WARRANTS AND DERIVATIVE LIABILITY &#8211; CONVERSION OPTION (Details 3)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/CapitalStockDetails" xlink:title="00000029 - Disclosure - CAPITAL STOCK (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://tapimmune.com/role/ContingenciesAndCommitmentsDetailsNarrative" xlink:title="00000030 - Disclosure - CONTINGENCIES AND COMMITMENTS (Details Narrative)" />
</link:linkbase>
